期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

瑞格列奈与地特胰岛素联合治疗2型糖尿病的效果观察

Observation of Insulin Detemir Combined With Repaglinide in Treatment of Type 2 Diabetes
下载PDF
导出
摘要 目的分析瑞格列奈与地特胰岛素联合治疗2型糖尿病的效果。方法随机抽取45例2型糖尿病患者,均采取瑞格列奈与地特胰岛素联合治疗。结果患者治疗后FBG、2 h PBG、Hb A1C较治疗前降低,P<0.05。患者治疗前后BMI比较,P>0.05。45例患者中仅1例轻微低血糖反应。结论瑞格列奈联合地特胰岛素治疗2型糖尿病效果佳,安全性高。 Objective To analyze effect of the repaglinide combined with insulin detemir for type 2 diabetes. Methods Randomly selected 45 cases of type 2 diabetes were taking repaglinide combination therapy with insulin detemir. Results The patients FBG,2 h PBG,Hb A1 C compared with before treatment reduced,P〈0.05. BMI compared before and after treatment,P〉0.05. 45 patients,only one case of mild hypoglycemia. Conclusion Repaglinide plus insulin detemir in treatment of type 2 diabetes,the effect is good,safe.
作者 李小囡
机构地区 吉林省人民医院内分泌二疗区
出处 《中国卫生标准管理》 2015年第30期98-99,共2页 China Health Standard Management
关键词 瑞格列奈 地特胰岛素 2型糖尿病 Repaglinide Insulin detemir Type 2 diabetes
分类号 R587.1 [医药卫生—内分泌]
  • 相关文献

参考文献2

二级参考文献16

  • 1Cryer PE, Davis SN, Shamoon H. Hypoglycemia in diabetes. Diabetes Care, 2003, 26:1902-1912.
  • 2Klein O, Lynge J, Endahl L, et al. Albumin-bound basal insu- lin analogues (insulin detemir and NN344) .. Comparable time- action profiles but less variability than insulin glargine in type 2 diabetes. Diabetes Obes and Metab, 2007, 9:290-299.
  • 3Monnier L, Mas E, Ginet C, et al. Activation of oxidative stress by acute glueose fluctuations compared with sustained ehronic hyperglycemia in patients with type 2 diabetes. JAMA, 2006, 295..1681-1687.
  • 4Hallschmid M, Jauch-Chara K, Korn O, et al. Euglycemic in- fusion of insulin detemir compared with human insulin appears to increase direct current brain potential response and reduces food intake while inducing similar systemic effects. Diabetes, 2010, 59:1101-1107.
  • 5Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
  • 6Soran H,Younis N.Insulin detemir:a new basal insulin analogue[J].Diabetes Obes Metab,2006,8(1):26-30.
  • 7Dornhorst A,Lüddeke HJ,Honka M,et al.Safety and efficacy of insulin detemir basal-bolus therapy in type 1 diabetes patients:14-week data from the European cohort of the PREDICTIVE study[J].Curr Med Res Opin,2008,24(2):369-376.
  • 8Dornhorst A,Lüddeke HJ,Sreenan S,et al.Safety and efficacy of insulin detemir in clinical practice:14-week follow-up data from type 1 and 2 diabetes patients in the PREDICTIVE European cohort[J].Int J Clin Pract,2007,61(3):523-528.
  • 9Kurtzhals P,Sch(a)ffer L,Sφrensen A,et al.Correlations of receptor binding and metabolic and mitogenic potencies of insulin analogs designed for clinical use[J].Diabetes,2000,49(6):999-1005.
  • 10袁慧娟,史晓阳,赵志刚,汪艳芳,王遂军,虎子颖,苏永,张会峰,郑瑞芝.瑞格列奈对2型糖尿病患者早时相胰岛β细胞功能影响的临床研究[J].中国糖尿病杂志,2011,19(3):210-212. 被引量：6

共引文献38

中国卫生标准管理
2015年 第30期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部